Benzinga | Aug 5, 2021 05:30PM EDT

Chembio Diagnostics Q2 EPS $(0.45) Misses $(0.27) Estimate, Sales $6.46M Miss $8.53M Estimate

Chembio Diagnostics (NASDAQ:CEMI) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.27) by 66.67 percent. This is a 7.14 percent decrease over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $6.46 million which missed the analyst consensus estimate of $8.53 million by 24.24 percent. This is a 26.43 percent increase over sales of $5.11 million the same period last year.